시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 의료용 바이오미메틱스 시장 보고서(2025년)
Medical Biomimetics Global Market Report 2025
상품코드 : 1825445
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의료용 바이오미메틱스 시장의 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.3%로 504억 달러로 성장할 전망입니다. 예측기간의 성장은 장기 이식 수요 증가, 바이오미메틱스 용도의 인지도 향상, 헬스케어 지출 증가, 바이오테크놀러지 부문의 확대, 조직공학의 진보 등에 기인할 것으로 전망됩니다. 예측기간의 주요 동향으로는 바이오인스파이어 인공 장비, 생체 모방 센서, 합성 생물학 용도, 스마트 약물전달 시스템, 바이오인스파이어 로봇, 맞춤의료, 3D 프린팅 기술, 진단용 인공지능, 나노기술 용도, 재생의료 등이 있습니다.

향후 5년간의 예측 성장률 6.3%는 과거 예측에서 0.1% 소폭 감소한 수치입니다. 이러한 성장세 둔화는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 인상은 스웨덴과 싱가포르에서 조달하는 생체 공학적 조직 발판과 합성 인공 혈관의 비용을 인상시키고 재생 치료를 지연시켜 생명공학 개발 비용을 증가시킴으로써 미국의 연구 개발(R&D)에 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 예상됩니다.

비만과 심장병의 유병률 증가는 의료용 바이오미메틱스 시장의 성장을 가속할 것으로 예측됩니다. 비만은 과도한 체지방이 건강에 해로운 수준까지 축적된 상태이며, 심장 질환은 심장과 혈관에 영향을 미치는 다양한 상태를 포함합니다. 바이오미메틱스는 당뇨병과 비만과 같은 증상을 가진 사람의 건강 관리를 돕는 장비와 의지와 같은 보조기구의 개발에 중요한 역할을 합니다. 예를 들어, 2022년 8월 미국의 비영리 의료 단체인 미국 심장병학회(American College of Cardiology)의 보고서는 2025년부터 2060년까지 미국에서 4대 심혈관계 위험 인자의 전반적인 증가를 예측했습니다. 가장 높은 증가가 예상된 것은 당뇨병으로 39.3% 증가한 5,500만명, 이어서 지질이상증(27.6% 증가한 1억 2,600만명), 고혈압(25.1% 증가한 1억 6,200만명), 비만(18.3% 증가한 1억 2,600만명)으로 이어졌습니다. 또한 심혈관질환 중에서 특히 뇌졸중(33.8%→1,500만명), 심부전(33.4%→1,300만명), 허혈성 심질환(30.7%→2,900만명), 심장 발작(16.9%→1,600만명)의 비율도 크게 증가하고 있습니다. 그 결과 비만과 심장병 증가율이 의료용 바이오미메틱스 시장의 확대에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Medical biomimetics refers to the development and application of innovative technologies that replicate and enhance natural physiological processes, aiming to create functional and biomechanically optimized solutions in the field of healthcare. Medical biomimetics plays a crucial role in advancing the field of artificial organs and tissues. It is extensively employed in the design of drug delivery systems that emulate biological processes, improving the precision and efficiency of targeted medication delivery.

The main types of medical biomimetics are cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the study and application of principles inspired by nature to develop innovative solutions for heart and vascular-related medical challenges. These are used in various applications such as wound healing, tissue engineering, drug delivery, and others and are used by various end-users such as hospitals, specialty clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The main types of medical biomimetics are cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the study and application of principles inspired by nature to develop innovative solutions for heart and vascular-related medical challenges. These are used in various applications such as wound healing, tissue engineering, drug delivery, and others and are used by various end-users such as hospitals, specialty clinics, and others.

The medical biomimetics market size has grown strongly in recent years. It will grow from $36.6 billion in 2024 to $39.44 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increased biomimetic materials, increased research funding, aging population, rising chronic diseases.

The medical biomimetics market size is expected to see strong growth in the next few years. It will grow to $50.4 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing demand for organ transplants, growing awareness of biomimetics applications, rising healthcare expenditure, expanding biotechnology sector, advancements in tissue engineering. Major trends in the forecast period include Bio-inspired prosthetics, biomimetic sensors, synthetic biology applications, smart drug delivery systems, biologically inspired robotics, Personalized medicine, 3D printing technologies, artificial intelligence in diagnostics, nanotechnology applications, regenerative medicine.

The forecast of 6.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. research and development (R&D) by driving up the cost of bioengineered tissue scaffolds and synthetic vascular grafts sourced from Sweden and Singapore, delaying regenerative therapies and increasing biotech development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of obesity and heart disease is expected to drive the growth of the medical biomimetics market. Obesity is a condition in which excess body fat accumulates to unhealthy levels, while heart disease encompasses a variety of conditions that affect the heart and blood vessels. Biomimetics plays a crucial role in developing assistive devices, such as orthotics and prosthetics, that can help individuals with conditions like diabetes or obesity manage their health. For example, in August 2022, a report by the American College of Cardiology, a US-based non-profit medical association, projected an increase in all four major cardiovascular risk factors in the United States from 2025 to 2060. The largest rise was anticipated in diabetes, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). The study also indicated significant increases in cardiovascular disease rates, particularly for stroke (33.8% to 15 million), heart failure (33.4% to 13 million), ischemic heart disease (30.7% to 29 million), and heart attack (16.9% to 16 million). As a result, the growing rates of obesity and heart disease are contributing to the expansion of the medical biomimetics market.

Major companies operating in the medical biomimetics market are focused on developing innovative products with advanced technologies, such as suture anchor system to increase their profitability in market. A suture anchor system is a medical device used in orthopedic and sports medicine procedures for securing soft tissues, such as tendons or ligaments, to bone. Suture anchor systems strive to replicate and improve upon the natural attachment of soft tissues to bone, offering a functional and biomechanically optimized solution mirroring physiological tissue connections in the human body. For instance, in December 2022, Stryker Corporation, a US-based multinational medical technologies company, launches Citrefix, a disposable suture anchor system, incorporates a resorbable biomimetic anchor body using Citregen, an elastomeric material crafted from a citrate polymer, specifically engineered to emulate bone chemistry. This design allows for controlled resorption without inducing chronic inflammation. It is a disposable suture anchor system that is designed to help grafted tissue heal and healthy bone grow when used in orthopedic surgical applications.

In July 2024, Edwards Lifesciences, a US-based medical technology company, acquired Innovalve Bio Medical for $300 million. This acquisition allows Edwards to reinforce its position in the expanding market for TMVR devices, which is expected to experience significant growth in the coming years. Innovalve Bio Medical is an Israel-based provider of medical biomimetics.

Major companies operating in the medical biomimetics market are BASF SE, Bayer Aktiengesellschaft, Abbott Laboratories, Stryker Corporation, Zimmer Biomet Holdings Inc., Otsuka Medical Device Company Ltd., LivaNova PLC, Ossur hf., Forschungszentrum Julich GmbH, Biohorizons Implant Systems Inc., Inventia Plc, Blatchford Limited, Keystone Dental Corporation, Xtant Medical Holdings Inc., AVINENT Science and Technology, SynTouch Inc., Curasan Inc., CorNeat Vision Inc., Hstar Technologies Co. Ltd., Veryan Medical Ltd., Swedish Biomimetics 3000 ApS, Osteopore International Pte Ltd., KitoTech Medical Ltd., Vandstrom Inc.

North America was the largest region in the medical biomimetics market in 2024. The regions covered in the medical biomimetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical biomimetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical biomimetics market consists of sales of diagnostic tools, wound healing products, bio-inspired robotics, bioelectronic devices and regenerative medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Biomimetics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical biomimetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for medical biomimetics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical biomimetics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Medical Biomimetics Market Characteristics

3. Medical Biomimetics Market Trends And Strategies

4. Medical Biomimetics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Medical Biomimetics Growth Analysis And Strategic Analysis Framework

6. Medical Biomimetics Market Segmentation

7. Medical Biomimetics Market Regional And Country Analysis

8. Asia-Pacific Medical Biomimetics Market

9. China Medical Biomimetics Market

10. India Medical Biomimetics Market

11. Japan Medical Biomimetics Market

12. Australia Medical Biomimetics Market

13. Indonesia Medical Biomimetics Market

14. South Korea Medical Biomimetics Market

15. Western Europe Medical Biomimetics Market

16. UK Medical Biomimetics Market

17. Germany Medical Biomimetics Market

18. France Medical Biomimetics Market

19. Italy Medical Biomimetics Market

20. Spain Medical Biomimetics Market

21. Eastern Europe Medical Biomimetics Market

22. Russia Medical Biomimetics Market

23. North America Medical Biomimetics Market

24. USA Medical Biomimetics Market

25. Canada Medical Biomimetics Market

26. South America Medical Biomimetics Market

27. Brazil Medical Biomimetics Market

28. Middle East Medical Biomimetics Market

29. Africa Medical Biomimetics Market

30. Medical Biomimetics Market Competitive Landscape And Company Profiles

31. Medical Biomimetics Market Other Major And Innovative Companies

32. Global Medical Biomimetics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Biomimetics Market

34. Recent Developments In The Medical Biomimetics Market

35. Medical Biomimetics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기